Bluegrass Vascular Technologies
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
12500 Network Blvd Ste 308, San Antonio,...Phone Number
(210) 558-0819Website
www.bluegrassvascular.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Bluegrass Vascular Technologies
Bluegrass Vascular is focused on developing innovative lifesaving devices and methods to improve vascular access procedures. Their flagship product, the Surfacer Inside-Out Access Catheter System, aims to restore vein access for patients requiring therapies like hemodialysis and chemotherapy. The company addresses the limitations of current vascular access methods, particularly the complications associated with central venous catheters. By employing a unique, minimally invasive approach, Bluegrass Vascular seeks to enhance patient outcomes and reduce healthcare costs.Explore more
Bluegrass Vascular Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bluegrass Vascular Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Bluegrass Vascular Technologies has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bluegrass Vascular Technologies has new funding data
Congratulate Masked Content for being promoted to Masked Content at Bluegrass Vascular Technologies
Click to see if Bluegrass Vascular Technologies had a recent Job posting/layoffs
Product Launch: Get notified when Bluegrass Vascular Technologies launches new products
Bluegrass Vascular Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Bluegrass Vascular Technologies recently announced quarterly report
Check out if Bluegrass Vascular Technologies is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Bluegrass Vascular Technologies as Masked Content
Find 3 more new buyers
Compare Similar Companies to Bluegrass Vascular Technologies
Compare insights from companies similar to Bluegrass Vascular Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bluegrass Vascular Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Bluegrass Vascular Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Bluegrass Vascular Technologies.
Bluegrass Vascular Technologies financials insights
Gather financial insights about Bluegrass Vascular Technologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$4.5M
2022
Debt
$5M
Bluegrass Vascular Technologies Tech Stack
A closer look at the technologies used by Bluegrass Vascular Technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bluegrass Vascular Technologies
Sign Up For FreeTo access detailed company insights
Bluegrass Vascular is focused on developing innovative lifesaving devices and methods to improve vascular access procedures. Their flagship product, the Surfacer Inside-Out Access Catheter System, aims to restore vein access for patients requiring therapies like hemodialysis and chemotherapy. The company addresses the limitations of current vascula... Read More
